Average cost of multi drug-resistant tuberculosis treatment in India
India: Average cost of multi drug-resistant tuberculosis treatment was 400 constant 2022 US$ in 2024. ◆ Volatile
Latest (2024)
400 constant 2022 US$
Change on year
down 1.2%
World rank
87th
of 92 countries
All-time high
1,800 constant 2022 US$
in 2018
All-time low
330 constant 2022 US$
in 2021
Years of data
8
2017–2024
Average cost of multi drug-resistant tuberculosis treatment in India, 2017–2024
Source: WHO (2025) – with minor processing by Our World in Data. Measured in constant 2022 US$.
Analysis
The most recent figure for average cost of multi drug-resistant tuberculosis treatment in India is 400 constant 2022 US$, measured in 2024.
Compared with earlier readings it is down 1.2% on the previous year and down 73.3% over ten years.
India ranks 87th of 92 countries on this measure, in the bottom quarter.
Average cost of multi drug-resistant tuberculosis treatment in India, year by year
| Year | constant 2022 US$ | Change |
|---|---|---|
| 2017 | 1,500 constant 2022 US$ | — |
| 2018 | 1,800 constant 2022 US$ | +20.0% |
| 2019 | 1,800 constant 2022 US$ | +0.0% |
| 2020 | 700 constant 2022 US$ | -61.1% |
| 2021 | 330 constant 2022 US$ | -52.9% |
| 2022 | 386 constant 2022 US$ | +17.0% |
| 2023 | 405 constant 2022 US$ | +4.9% |
| 2024 | 400 constant 2022 US$ | -1.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 1,700 constant 2022 US$ | 1,500 constant 2022 US$ | 1,800 constant 2022 US$ | 3 |
| 2020s | 444.2 constant 2022 US$ | 330 constant 2022 US$ | 700 constant 2022 US$ | 5 |
Countries ranked near India
- 84 Togo 444 constant 2022 US$ compare
- 85 Algeria 440 constant 2022 US$ compare
- 86 Benin 426 constant 2022 US$ compare
- 88 Sierra Leone 369 constant 2022 US$ compare
- 89 Philippines 310 constant 2022 US$ compare
- 90 Tajikistan 257 constant 2022 US$ compare
More health data for India
- Un projection of annual infant deaths, annual growth rate -2.12 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.4372 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,332 deaths per 1,000 people (2090)
- Number of infants who die before age 1 44,822 deaths (2100)
- Population ages 0-14, female, annual growth rate -0.7713 % change on previous year (2025)
- Population ages 0-14, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 0-14, female, per capita 0.116 units per person (2025)
- Population ages 0-14, male, annual growth rate -0.9514 % change on previous year (2025)
- Population ages 0-14, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 0-14, male, per capita 0.1259 units per person (2025)
Frequently asked questions
- What is average cost of multi drug-resistant tuberculosis treatment in India?
- Average cost of multi drug-resistant tuberculosis treatment in India was 400 constant 2022 US$ in 2024, according to WHO (2025) – with minor processing by Our World in Data.
- What is the highest average cost of multi drug-resistant tuberculosis treatment recorded in India?
- The highest recorded value was 1,800 constant 2022 US$ in 2018.
- What is the lowest average cost of multi drug-resistant tuberculosis treatment recorded in India?
- The lowest recorded value was 330 constant 2022 US$ in 2021.
- How does India rank for average cost of multi drug-resistant tuberculosis treatment?
- India ranks 87th out of 92 countries with data for 2024.
- Is average cost of multi drug-resistant tuberculosis treatment rising or falling in India?
- Over the last ten years it is down 73.3%. The long-run trend across the full record is volatile.
- Where does this India data come from?
- The figures come from WHO (2025) – with minor processing by Our World in Data, published as part of Average cost of multi drug-resistant tuberculosis treatment. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 8 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Average cost of drugs spent per patient starting multidrug-resistant tuberculosis treatment, excluding buffer stock.